mRNA |
nakiterpiosin |
CTRPv2 |
pan-cancer |
AAC |
-0.063 |
0.05 |
mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.062 |
0.05 |
mRNA |
Bleomycin |
CTRPv2 |
pan-cancer |
AAC |
-0.071 |
0.05 |
mRNA |
PLX4720 |
GDSC1000 |
pan-cancer |
AAC |
-0.058 |
0.05 |
mRNA |
Bortezomib |
CTRPv2 |
pan-cancer |
AAC |
-0.066 |
0.05 |
mRNA |
CH5424802 |
GDSC1000 |
pan-cancer |
AAC |
0.064 |
0.05 |
mRNA |
cyanoquinoline 11 |
CTRPv2 |
pan-cancer |
AAC |
-0.097 |
0.05 |
mRNA |
MK-2206 |
GDSC1000 |
pan-cancer |
AAC |
0.068 |
0.05 |
mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.067 |
0.06 |
mRNA |
Docetaxel |
GDSC1000 |
pan-cancer |
AAC |
-0.059 |
0.06 |